logo

EUDA

EUDA Health·NASDAQ
--
--(--)
Market Open: --
--
--(--)
Pre-Market: --
Signals Analysis
Bullish signal 0
Bearish signal 1
Bearish Engulfing

Key Stats

0.0000DAY`S RANGE0.0000
0.000052 WK RANGE0.0000
0.0000
0.0000
--
--
--
--
--
--
--
--
--
--
--
--
--
--
0.0000
0.0000
0.0000
0.0000

About EUDA

Euda Health Holdings Limited

A next-generation Southeast Asian healthcare-technology provider

Healthcare Technology
01/21/2021
12/14/2021
NASDAQ Stock Exchange
117
12-31
Common stock
60 Kaki Bukit Place #03-01 Eunos Techpark Singapore 415979
--
EUDA Health Holdings Limited was incorporated under the laws of the British Virgin Islands on January 21, 2021. EUDA Health Limited is a Singapore-based health technology company that operates a digital healthcare ecosystem pioneered in Southeast Asia to deliver better outcomes through personalized healthcare, make healthcare affordable and accessible, and improve the patient experience. The company's proprietary unified artificial intelligence platform rapidly assesses a patient's medical history, classifies conditions, digitally connects patients with clinicians, and predicts optimal treatment outcomes. EUDA Health's holistic approach supports patients at all stages of care, including health and prevention, urgent care and emergency situations, prior illness and aftercare services.

Company Financials

EPS

EUDA has released its 2022 Q3 earnings. EPS was reported at -0.04, versus the expected 0, missing expectations. The chart below visualizes how EUDA has performed over recent quarters, highlighting trends in earnings surprises.

Revenue & Expenses

EUDA has released its 2023 Q2 earnings report, with revenue of 1.11M, reflecting a YoY change of -54.41%, and net profit of -6.10M, showing a YoY change of -227.85%. The Sankey diagram below clearly presents EUDA's revenue sources and cost distribution.

Forecast

Wall Street Opinions

Price Target

Volume Profile

Trade Flow Insight

Seasonals

Community Forum

Loading...

Related News

No articles available

Related Symbols

You can ask Aime